Every day, Anicet Mbida makes us discover an innovation that could well change the way we consume.
This Tuesday, he is interested in an innovation in the medical field, a virtual double to minimize the risks during surgical operations and to test treatments in complete safety.
Innovation in medicine this morning. To minimize the risks, we will soon have a virtual twin on which we can test treatments before administering them to us in real life.
Tests carried out on a clone, a duplicate of his body.
Not in the flesh, a digital double that lives in a computer simulation.
This offers a lot of advantages because the doctor will be able to try different drugs, different dosages on the virtual body to find exactly the treatment which corresponds and which causes the fewest side effects.
Same thing in surgery.
We will avoid surprises by repeating the operation on the digital twin.
This will also allow all instruments to be programmed more precisely, a critical step in heart or brain surgery.
This is the new trend in medical research: relying on the virtual to provide better care in the real world.
This should give us medicine that is more personalized and, above all, much safer.
How do we manage to create this virtual twin?
By combining a whole series of examinations by scanner, MRI or radio.
We even go so far as to sequence the DNA to have the most faithful possible representation of everything that is happening in the human body.
It requires phenomenal computing power.
So, unfortunately, we cannot yet model an entire human body.
However, it already works on some organs.
At the Rennes University Hospital, for example, simulation is used to prepare for cardiac operations.
Much is now expected from the work of CompBioMed, a project funded by the European Union, which aims precisely to create virtual duplicates of patients.
A small revolution is brewing in medicine.
And this time, Europe is on the front line.